Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to ...
Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.
As the Jacksonville Jaguars prepare to face the Miami Dolphins, much will be made about the difficulty of stopping the Dolphins offense. Last season, the Dolphins’ offense ranked as one of the ...
Eupraxia Pharmaceuticals Inc. (EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with ...
16d
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...
The Company's presentation is at 8:00 a.m. ET on Monday, September 9, 2024 . Eupraxia invites all interested parties to view the presentation by clicking on the following link: A webcast of the ...
A webcast of the presentation will also be available on the Events and Presentations page of the Company's website here. About Eupraxia Pharmaceuticals Inc. Eupraxia is a clinical-stage ...
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback